An Illinois federal judge approved the dismissal of a whistleblower lawsuit against Omnicare, following a settlement agreement on July 9, according to local media reports.
Kindred breaks with PharMerica, plans to partner with Omnicare
By
Elizabeth Newman
Jun 26, 2013
Kindred Healthcare will split with pharmacy partner PharMerica and join forces with Omnicare at the end of 2013, according to documents filed with the Securities and Exchange Commission.
Kindred teams with Omnicare, splits with skilled nursing pharmacy PharMerica
By
McKnight's Staff
Jun 24, 2013
Major long-term care provider Kindred Healthcare will split with its current pharmacy partner, PharMerica, and team with the sector’s largest pharmacy, Omnicare, at the end of 2013, according to...
Judge dismisses claims of ‘nationwide’ Medicare fraud in Omnicare antipsychotics case
By
McKnight's Staff
May 23, 2013
Long-term care pharmacy Omnicare will not face charges that it engaged in “nationwide” Medicare fraud for off-label antipsychotics prescriptions, a federal judge recently ruled. However, the...
David fights on after long-term care Goliath decides to bow out
By
James M. Berklan
Aug 29, 2012
The headlines were big. Really big. And they involved a long-term care corporate giant settling yet another lawsuit. But they didn’t tell the story I really wanted to know about. And that you probably...
Omnicare to settle whistle-blower suit
By
McKnight's Staff
Aug 27, 2012
Omnicare agreed to settle over claims it provided a kickback when it bought Total Pharmacy services LLC in 2004. Terms of the deal were not released.
Omnicare will pay $50 million over controlled substances charges
May 14, 2012
Long-term care pharmacy provider Omnicare has agreed to pay the government $50 million to settle charges that it illegally dispensed controlled medications to long-term care residents.
Leading long-term care pharmacy provider Omnicare, which announced this week that it has ended its efforts to takeover competitor PharMerica, posted a profit in the fourth quarter.
Omnicare extends purchase offer for PharMerica until January
Dec 07, 2011
Omnicare announced Monday that it is extending its offer to purchase all outstanding shares of rival PharMerica for $15 per share to Jan. 20. The original offer was scheduled to expire Dec. 2.
Rebuffed by PharMerica top brass, Omnicare appeals to board members in purchase attempt
Aug 24, 2011
Omnicare’s top management decided private negotiations with their counterparts at takeover target PharMerica were not working. So on Tuesday, Omnicare went public with an announced $15 per share...